Literature DB >> 32140476

Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy.

Heather A Lillemoe1, Jean-Nicolas Vauthey1.   

Abstract

An increasing number of patients with colorectal cancer (CRC) are presenting with synchronous disease to the liver. The optimal surgical approach for this complex patient group is controversial, but ultimately depends on individual patient characteristics and institutional practices. Surgical strategies include the traditional staged approach, a combined colorectal and liver resection, or a liver-first reverse approach. In this review, the authors will provide an overview of each strategy, including case examples demonstrating the benefits of the more recently described liver-first approach, while arguing for individualized planning and multidisciplinary discussion for every patient. 2020 Hepatobiliary Surgery and Nutrition. All rights reserved.

Entities:  

Keywords:  Synchronous colorectal liver metastases (SCRLM); liver-first reverse approach; multidisciplinary discussion

Year:  2020        PMID: 32140476      PMCID: PMC7026786          DOI: 10.21037/hbsn.2019.05.14

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  57 in total

1.  Indicators of prognosis after hepatic resection for colorectal secondaries.

Authors:  J Scheele; R Stangl; A Altendorf-Hofmann; F P Gall
Journal:  Surgery       Date:  1991-07       Impact factor: 3.982

2.  A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer.

Authors:  M Ychou; W Hohenberger; S Thezenas; M Navarro; J Maurel; C Bokemeyer; E Shacham-Shmueli; F Rivera; C Kwok-Keung Choi; A Santoro
Journal:  Ann Oncol       Date:  2009-06-30       Impact factor: 32.976

3.  RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.

Authors:  Jean-Nicolas Vauthey; Giuseppe Zimmitti; Scott E Kopetz; Junichi Shindoh; Su S Chen; Andreas Andreou; Steven A Curley; Thomas A Aloia; Dipen M Maru
Journal:  Ann Surg       Date:  2013-10       Impact factor: 12.969

4.  In patients with colorectal liver metastases, can we still rely on number to define treatment and outcome?

Authors:  Claudius Conrad; Nancy You; Jean-Nicolas Vauthey
Journal:  Oncology (Williston Park)       Date:  2013-11       Impact factor: 2.990

5.  Management of colorectal cancer with synchronous liver metastases: impact of multidisciplinary case conference review.

Authors:  Kerollos N Wanis; Karen Pineda-Solis; Mauro E Tun-Abraham; Jake Yeoman; Stephen Welch; Kelly Vogt; Julie Ann M Van Koughnett; Michael Ott; Roberto Hernandez-Alejandro
Journal:  Hepatobiliary Surg Nutr       Date:  2017-06       Impact factor: 7.293

6.  Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial.

Authors:  Guillaume Portier; Dominique Elias; Olivier Bouche; Philippe Rougier; Jean-François Bosset; Jean Saric; Jacques Belghiti; Pascal Piedbois; Rosine Guimbaud; Bernard Nordlinger; Roland Bugat; Franck Lazorthes; Laurent Bedenne
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

7.  Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.

Authors:  Hiroshi Nakano; Elie Oussoultzoglou; Edoardo Rosso; Selenia Casnedi; Marie-Pierre Chenard-Neu; Patrick Dufour; Philippe Bachellier; Daniel Jaeck
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

Review 8.  The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review.

Authors:  Santhalingam Jegatheeswaran; James M Mason; Helen C Hancock; Ajith K Siriwardena
Journal:  JAMA Surg       Date:  2013-04       Impact factor: 14.766

9.  Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

Authors:  Dan G Blazer; Yoji Kishi; Dipen M Maru; Scott Kopetz; Yun Shin Chun; Michael J Overman; David Fogelman; Cathy Eng; David Z Chang; Huamin Wang; Daria Zorzi; Dario Ribero; Lee M Ellis; Katrina Y Glover; Robert A Wolff; Steven A Curley; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  J Clin Oncol       Date:  2008-10-20       Impact factor: 44.544

10.  Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10.

Authors:  Laurence E McCahill; Greg Yothers; Saima Sharif; Nicholas J Petrelli; Lily Lau Lai; Naftali Bechar; Jeffrey K Giguere; Shaker R Dakhil; Louis Fehrenbacher; Samia H Lopa; Lawrence D Wagman; Michael J O'Connell; Norman Wolmark
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

View more
  6 in total

1.  Surgical treatment of colorectal cancer liver metastases: individualized comprehensive treatment makes a difference.

Authors:  Zhiwen Luo; Xinyu Bi
Journal:  Hepatobiliary Surg Nutr       Date:  2021-12       Impact factor: 7.293

Review 2.  Colorectal liver metastases: state-of-the-art management and surgical approaches.

Authors:  Timothy E Newhook; Jean-Nicolas Vauthey
Journal:  Langenbecks Arch Surg       Date:  2022-04-09       Impact factor: 2.895

3.  Humanized Fluorescent Tumor-associated Glycoprotein-72 Antibody Selectively Labels Colon-cancer Liver Metastases in Orthotopic Mouse Models.

Authors:  Hannah M Hollandsworth; Hiroto Nishino; Michael Turner; Siamak Amirfakhri; Filemoni Filemoni; Robert M Hoffman; Paul J Yazaki; Michael Bouvet
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

4.  Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis.

Authors:  Jiefeng Zhao; Jinfeng Zhu; Rui Sun; Chao Huang; Rongfa Yuan; Zhengming Zhu
Journal:  BMC Cancer       Date:  2021-05-06       Impact factor: 4.430

Review 5.  Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases.

Authors:  Gianluca Rompianesi; Francesca Pegoraro; Carlo Dl Ceresa; Roberto Montalti; Roberto Ivan Troisi
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

6.  Prognostic Value of Lymph Node Ratio in Patients with Resected Synchronous Colorectal Liver Metastases and Less Than 12 Examined Lymph Nodes.

Authors:  Sorin Tiberiu Alexandrescu; Florin M Selaru; Andrei S Diaconescu; Cristian A Zlate; Diana Blanita; Razvan T Grigorie; Narcis O Zarnescu; Vlad Herlea; Irinel Popescu
Journal:  J Gastrointest Surg       Date:  2021-07-13       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.